Marumae Co.,Ltd. announced its earnings summary for the fiscal year ended August 2026. Revenue of ¥20.4 billion, operating profit of ¥4.1 billion and net income of ¥3.5 billion represented substantial increases in both revenue and profit, while the public offering improved the equity ratio. The share price has recently moved through a sharp rebound followed by a decline.
Marumae Co.,Ltd. released its earnings summary for the fiscal year ended August 2026 on 9 October. Revenue rose 79.2% year on year to ¥20.4 billion, operating profit increased 99.8% to ¥4.1 billion, and net income increased 157.6% to ¥3.5 billion, representing substantial increases across all indicators. Stronger AI and semiconductor demand and a recovery in FPD investment provided tailwinds, while rapid growth in the functional materials business drove consolidated performance higher. The equity ratio improved to 53.5% through a public offering.
In the immediate market response, the share price rose 7.63% from the previous day to ¥2,243 on 9 October and was bought up to ¥2,275 on 13 October. It then fell back 11.69% to ¥1,980 on 15 October, resulting in volatile trading.
Future performance checkpoints include expanding semiconductor-related demand, higher capacity utilisation and the company's response to requests for increased vacuum chamber production. Attention is also focused on achieving integrated production through the acquisition of part of a surface treatment business, as well as strengthening the financial base and increasing investment capacity. At the same time, risks include market cycles, dependence on major customers, and securing personnel and external contractors in connection with increased production.
The earnings summary emphasises that, for the fiscal year ended August 2026, growth in the functional materials business driven by expanding AI and semiconductor demand and a recovery in FPD investment lifted consolidated performance. Going forward, attention will also need to be paid to order trends, raw material prices, goodwill amortisation and impairment risks, and the impact of borrowing terms.